Pharmaceutical Business review

Renovo Group names interim CFO

Mr Blain has been operating his own consultancy for the past year. Prior to this Mr Blain was finance director and company secretary at Drew Scientific Group. Mr Blain trained as a chartered accountant at WT Walton & Son before serving nine years at PriceWaterhouseCoopers.

Rodger Pannone, chairman of Renovo, said: “We are delighted to welcome David to the company. The board would also like to thank Rob for his sound advice and significant contribution over the past seven years during which time Renovo has evolved from a private to public entity.”